Do organic solvents induce changes in the dopaminergic system? Positron emission tomography studies of occupationally exposed subjects

International Archives of Occupational and Environmental Health

Volumn 70, Issue 3, 1997, Pages 180-186

  Edling, Christer ^a   Hellman, Björn ^a   Arvidson, Björn ^a   Andersson, Jesper ^b   Hartvig, Per ^b   Lilja, Anders ^b   Valind, Sven ^b   Långström, Bengt ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Dopamine; Organic solvents; Positron emission tomography; Toxic encephalopathy

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; NOMIFENSINE; ORGANIC SOLVENT; RACLOPRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; HUMAN; ISOTOPE LABELING; MALE; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; POSITRON EMISSION TOMOGRAPHY; SYNAPTOSOME;

BRAIN; DOPAMINE; HUMANS; MALE; MIDDLE AGED; NEUROBEHAVIORAL MANIFESTATIONS; OCCUPATIONAL EXPOSURE; ORGANIC CHEMICALS; SOLVENTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030810001     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004200050204     Document Type: Article

References (40)

1. Andersson K, Fuxe K, Toftgård R, Nilsen OG, Eneroth P, Gustafsson J-Å (1980) Toluene-induced activation of certain hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion. Toxicol Lett 5 : 393-398
2. Andersson K, Fuxe K, Toftgård R, Nilsen OG, Eneroth P, Gustafsson J-A, Battistini N, Calza L (1983) Increased amine turnover in several hypothalamic noradrenaline terminal systems and changes in GH, LH and prolactin secretion in the male rat by low concentrations of toluene. Neurotoxicology 4 : 43-56
3. Axelson O, Hogstedt C (1988) On the health effects of solvents. In: Zenz C (ed) Occupational medicine. Principles and practical applications. Year Book Medical, Chicago, pp 774-784
4. Baker E (1994) A review of recent research on health effects of human occupational exposure to organic solvents. J Occup Med 36 : 1079-1092
5. Bergström M, Litton J, Eriksson L, Bohm C, Blomqvist G (1982) Determination of object contour from projections for attenuation correction in cranial positron emission tomography. J Comput Assist Tomogr 6 : 365-372
6. 11C-labelled L-tyrosine and L-DOPA. Acta Chem Scand 44 : 183-188
7. Bowsher RR, Henry DP (1986) Aromatic 1-amino acid decarboxylase. Biochemistry and functional significance. In: Boulton AA, Baker GB, Yu PH, (eds) Neuromethods 5. Series I, Neurochemistry. Neurotransmitter enzymes. Humana Press, Clifton, N.J., pp 33-78
8. Cranmer JM, Goldberg L (1986) Neurobehavioral effects of solvents. Neurotoxicology 7 : 1-95
9. 2+)ATPase and fluidity of synaptosomal membrane isolated from rat brain. Pharmacol Toxicol 65 : 140-145
10. Edling C (1985) Nervous system symptoms and signs associated with long-term organic solvent exposure. In: Chronic effects of organic solvents on the central nervous system and diagnostic criteria. (Report of a joint World Health Organization/Nordic Council Ministers Working Group) WHO, Copenhagen, pp 149-155
11. Ekberg K, Hane M, Berggren T (1988) Psychologic effects of exposure to solvents and other neurotoxic agents in the work environment. In: Zenz C (ed) Occupational medicine. Principles and practical applications. Year Book Medical, Chicago, pp 785-795
12. Eriksson H, Tedroff J, Thoumas KA, Aquilonius SM, Hartvig P, Fasth KJ, Bjurling P, Långström B, Hedström KG, Heilbrom E (1992) Manganese-induced brain lesions in Macaca fascicuklaris as revealed by positron emission tomography and magnetic imaging. Arch Toxicol 66 : 403-407
13. Errebo-Knudsen EO, Olsen F (1986) Organic solvent and presenile dementia (the painter's syndrome). A critical review of the Danish literature. Sci Total Env 48 : 45-67
14. 2-dopamine receptors studied by PET-A comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9 : 696-708
15. Fuxe K, Andersson K, Nilsen OG, Toftgård R, Eneroth P, Gustafsson J-Å (1982) Toluene and telencephalic dopamine: selective reduction of amine turnover in discrete DA nerve terminal systems of the anterior caudate nucleus by low concentrations of toluene. Toxicol Lett 12 : 115-123
16. Glass D, Spurgeon A, Calvert I, Clark J, Harrington M (1994) Retrospective assessment of solvent exposure in paint manufacturing. Occup Environ Med 51 : 617-625
17. Grasso P, Sharratt M, Davies DM, Irvine D (1984) Neurophysiological and psychological disorders and occupational exposure to organic solvents. Food Chem Toxicol 22 : 819-852
18. 11C]DOPA in humans studied by positron emission tomography. J Neural Transm 86 : 25-41
19. Holte S, Eriksson L, Dahlbom M (1989) A preliminary evaluation of the Scanditronix PC 2048-15B brain scanner. Eur J Nucl Med 15 : 719-721
20. Kops R, Herzog H, Schmid A, Holte S, Feinendegen L (1990) Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr 14 : 437-445
21. Leenders KU, Aquilonius SM, Bergström K, Bjurling P, Crossman A, Eckernäs SÅ, Gee A, Hartvig P, Lundqvist H, Långström B, Rimland A, Tedroff J (1988) Unilateral MPTP lesions in rhesus monkeys: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers. Brain Res 445 : 61-67
22. 11C]DOPA and its metabolites for the validation of positron emission tomography studies. J Pharm Biomed Analysis 13: 361-367
23. 11C]methionine. J Nucl Med 28 : 1037-1040
24. Morrow LA, Callender T, Lottenberg S, Buchsbaum MS, Hodgson MJ, Robin N (1990) PET and neurobehavioural evidence of tetrabromoethane encephalopathy. J Neuropsychol Clin Neurosci 2 : 431-435
25. Mutti A, Falzoi M, Romanelli A, Bocchi MC, Ferroni C, Franchini I (1988) Brain dopamine as a target for solvent toxicity: effects of some monocyclic aromatic hydrocarbons. Toxicology 49 : 77-82
26. NIOSH (1987) Organic solvent neurotoxicity. Current Intelligence Bulletin 48. National Institute for Occupational Safety and Health, Bethesda
27. NRC (1992) National Research Council. Environmental neurotoxicology. National Academy Press. Washington, D.C.
28. Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3 : 1-7
29. Salmon E, Brooks DJ, Leenders KL, Turton DR, Hume SP, Cremer JE, Jones T, Frackowiak RSJ (1990) A two-compartment description and kinetic procedure for measuring regional cerebral (C-11) nomifensine uptake using positron emission tomography. J Cereb Blood Metab 10 : 307-316
30. 18F]fluoro L-DOPA in Parkinson's disease measured with positron emission tomography. Acta Neurol Scand 81 : 24-30
31. 11C] L-3,4-hydroxy-phenylalanine (DOPA) in the primate by positron emission tomography. Acta Neurol Scand 85 : 166-173
32. Tedroff J, Hartvig P, Bjurling P, Andersson Y, Antoni G, Långström B (1991) Central action of benzerazide after COMT inhibition demonstrated in vivo by PET. J Neural Transm 85 : 11-17
33. 11C]methyl-nomifensine a ligand for evaluation of monoamine re-uptake sites by use of positron emission tomography. Appl Radiat Isot 40 : 171-176
34. 3H-N-propylnorapomorphine binding characteristics in rat striatal membranes. Neurosci Lett 82 : 181-187
35. 2 receptors in rat striatal membranes also following treatment with toluene. Acta Physiol Scand 35 : 443-448
36. 1 prevents and reverses toluene-induced increases in membrane-fluidity and calcium levels in rat brain synaptosomes. Brain Res 508 : 210-214
37. von Euler G, Ögren S-O, Bondy SC, McKee M, Warner M, Gustafsson J-Å, Eneroth P, Fuxe K (1991) Subacute exposure to low concentrations of toluene affects dopamine-mediated locomotor activity in the rat. Toxicology 67 : 333-349
38. 2 agonist binding in the rat. Toxicology 77: 223-232
39. Westermark K, Tedroff J, Thoumas KA. Hartvig P, Långström B, Andersson Y, Hörnfeit K, Aquilonius SM (1995) Neurological Wilson's disease: positron emission tomography studies with dopaminergic markers. Mov Disord 10 : 596-603
40. WHO (1985) Chronic effects of organic solvents on the central nervous system and diagnostic criteria. Joint World Health Organization/Nordic Council Ministers Working Group, Copenhagen